Quarterly report
Open the filing on sec.gov
USANA Health Sciences Inc (USNA)
NYSE: USNA · Medicinal Chemicals & Botanical Products · Salt Lake City, UT · filing with the SEC since 1996
Grade6.8
◀ Past 6.3● Present 7.3▶ Future 6.5
The companyfiscal 2026, as filed
Revenue$925M+8.3%
Net income$10.8M-74.4%
Earnings per share$0.58-73.5%
Operating cash flow$22.3M-63.4%
Cash$158M-12.9%
Debtn/a
Shareholders’ equity$533M+0.2%
Shares, diluted18.6M-3.1%
Return on equity2.0%
The recordfrom its filings
Filings in 202699
Newest filingNov 12 · 10-Q
Annual reportMar 16, 2026
Quarterly reportNov 12, 2026
Next report due10-K by Mar 19
Insider sales, 12 months$1.0M
Insider buys, 12 months$0.00
Patents granted6
Filer categoryAccelerated filer
Trailing twelve months to Oct 2026Revenue $906MNet income -$21.2MCash from operations $41.7Mthe four newest filed quarters added
Left: the newest annual report, with the change on the year before. Right: counted from the company's own filings with the SEC.
As filed, in USD. Nothing here is a forecast.
News
Results released
Open the filing on sec.gov
Insider trade report
Open the filing on sec.gov
Insider trade report
Open the filing on sec.gov
Insider trade report
Open the filing on sec.gov
Insider trade report
Open the filing on sec.gov
Insider trade report
Open the filing on sec.gov
Insider trade report
Open the filing on sec.gov
Insider trade report
Open the filing on sec.gov
Current report
Open the filing on sec.gov
Nothing of this kind is on the record for this company yet.
An outside story is shown by its headline, its source and its link only. The SI reads the page when you ask it to break one down.